muhammad-raza

Muhammad Raza, MD


EDUCATION/CERTIFICATONS:

2011

Board certified American board of Hematology.
Certified 11/17/2011, Certificate valid through 12/31/2021

 

2011

Board certified American board of Oncology
Certified 11/17/2011, Certificate valid through 12/31/2021

 

2008

Board certified American Board of Internal Medicine
Certified 08/25/2008, Certificate valid through 12/31/2018.

2003

ECFMG Certification

  • USMLE Step 1 score 94th percentile 2002
  • USMLE Step 2 score 98th percentile 2002
  • USMLE Step 3 score 82th percentile 2003

1995 - 2000

King Edward Medical College, Lahore, Pakistan.

  • Bachelor of Medicine and Surgery, M.B.B.S


POSTDOCTROL EDUCATION AND TRAINING:

2008 - 2011

University of Tennessee Cancer Institute, Memphis, TN

  • Fellowship training in Hematology/Oncology
  • 3 months elective rotation at Vanderbilt Ingram cancer center hematology/ stem cell transplant unit.
  • Spent 3rd year of fellowship training as a dedicated year for stem cell transplantation training.

2006 - 2008

University of Tennessee, Health Science Center, Memphis, TN

  • Residency Training in Internal Medicine

2005 - 2006

University of Tennessee, Health Science Center, Memphis, TN

  • Internship in Internal Medicine.
2003 - 2005

Time spent preparing for USMLE exams, applying for residency position and relocating to USA.

2002 - 2003

Voluntary Medical office at Dept of Medical Oncology Shaukat Khanum Memorial Cancer hospital and Research Center, Lahore. Pakistan for 6 months.

2001 - 2002

Voluntary House officer in Dept of Medicine Mayo hospital, Lahore. Pakistan.

 

PROFESSIONAL EXPERIENCE:

07/2011 till present:
Assistant professor in Division of hematology/oncology at University of Tennessee Cancer Institute, Memphis, TN

 

07/2011 till present:
Attending physician at Boston Baskin Cancer Foundation/Baptist Blood and Marrow transplant program.

 

LICENSURE:

Active medical license in State of Tennessee and Mississippi.

 

PUBLICATIONS:

  1. Spindle cell hemangioendothelioma. Dhawan SS, Raza M (Cutis. 2007 Feb; 79(2):125-8).
  2.  

  3. Intravascular B-cell lymphoma: an elusive diagnosis. Raza M, Qayyum S, Raza S, Goorha S . J Clin Oncol. 2012 May 20; 30(15):e144-5.
  4.  

  5. Co-author NCCN survivorship guidelines Version 1. 2013.
  6.  

PRESENTATIONS:

  1. Snider, J. N., Stelts, S. D., Awan, M., Raza, M., Goorha, S. Retrospective review of DPACE therapy as a salvage regimen in patients with relapsed multiple myeloma prior to autologous stem cell transplant. (Abstract selected for poster session at the 2012 ASBMT annual meeting)
  2.  

  3. Effect of race and co-morbidities on patterns of bevacizumab toxicity: a single institution experience. Raza, M. Raza, S. Zafar, L. Sachdev, J. Poster presentation at ASCO 2010.
  4.  

  5. Safety and Toxicity Analysis of Induction Chemotherapy (TPF) for Squamous Cell Carcinoma of Head and Neck (SCCHN) in an Inner-city Population, M. Raza, A. Farooq, M. ul Haq, J. Patel, J. Allen, S. Samant, F. Yunus. Presented at Multi-disciplinary Head and Neck cancer symposium, Chandler, AZ, Feb 2010.
  6.  

  7. A case of histoplasmosis presenting as tongue ulcer. Raza, M Oral Presentation at SGIM (southern society of general internal medicine), New Orleans Feb 2007.
  8.  

  9. Eosinophilia presenting with Acute lymphoblastic lymphoma ( ALL), Raza, M. Shafiqu, R. Hussain, A. Nath, R, Poster presentation at SGIM, New Orleans Feb 2007.

 

AWARDS/ ACHEIVEMENTS:

Consistent and superior performance in all major standardized exams and ABIM in-service exams. Usually ranked in the 90th percentile in these exams.

  • Silver Medal in Secondary School Examination, Multan, Pakistan.
  •  

  • Presidential Talent Scholarship in Secondary School Examination, Multan, Pakistan.
  •  

  • Talent Scholarship in Higher Secondary School Examination, Multan, Pakistan.
  •